Clinical Trials Directory

Trials / Completed

CompletedNCT03039426

Postoperative Cesarean Delivery Pain Relief; Diclofenac Versus Bupivacaine

A Randomized Comparison of Bupivacaine Peritoneal and Subcutaneous Infiltration Versus Diclofenac Intramuscular Injection for Postoperative Pain Relief in Patient Undergoing Cesarean Delivery

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
120 (actual)
Sponsor
Department of Medical Services Ministry of Public Health of Thailand · Other Government
Sex
Female
Age
20 Years – 50 Years
Healthy volunteers
Accepted

Summary

This randomized controlled trial, compared postoperative pain score in patient undergoing cesarean delivery between bupivacaine peritoneal and subcutaneous infiltration and diclofenac intramuscular injection

Detailed description

Postoperative cesarean delivery was painful that can effect daily activity, resulted in poor quality of life and required morphine injection to relief pain which had both maternal and breastfeeding infancy side effect. So this study compare efficacy of diclofenac and bupivacaine by measured the pain score and requirement of morphine injection.

Conditions

Interventions

TypeNameDescription
DRUGBupivacaine0.5% bupivacaine 20ml divided in two; 10 ml intraperitoneal infiltration and 10 ml subcutaneous infiltration
DRUGDiclofenacdiclofenac 75 mg intramuscular, 2 hours postoperation

Timeline

Start date
2017-01-01
Primary completion
2017-06-30
Completion
2017-12-30
First posted
2017-02-01
Last updated
2020-10-22

Locations

2 sites across 1 country: Thailand

Source: ClinicalTrials.gov record NCT03039426. Inclusion in this directory is not an endorsement.